Unique ID issued by UMIN | UMIN000015254 |
---|---|
Receipt number | R000017450 |
Scientific Title | Evaluation of macular microcircular alteration induced by glaucoma topical drugs using high resolution scannning LASER ophthalmoscope (SLO) |
Date of disclosure of the study information | 2014/09/25 |
Last modified on | 2018/03/29 14:05:02 |
Evaluation of macular microcircular alteration induced by glaucoma topical drugs using high resolution scannning LASER ophthalmoscope (SLO)
Evaluation of macular microcircular alteration induced by glaucoma topical drugs using high resolution scannning LASER ophthalmoscope (SLO)
Evaluation of macular microcircular alteration induced by glaucoma topical drugs using high resolution scannning LASER ophthalmoscope (SLO)
Evaluation of macular microcircular alteration induced by glaucoma topical drugs using high resolution scannning LASER ophthalmoscope (SLO)
Japan |
patients with:
glaucoma
ocular hypertension
Ophthalmology |
Others
NO
To assess the efficacy of high resolution scannning LASER ophthalmoscope (SLO) in detecting macular blood flow alteration induced by glaucoma topical drugs.
To assess the correlation among retinal blood flow parameters determined by high resolution SLO, laser speckle flowgraphy (LSFG), and optical coherence tomography (OCT).
Efficacy
Exploratory
Pragmatic
Not applicable
Blood flow rate in macular capillaries before and at 7days, 1 and 3months after starting topical anti-glaucoma medications
Diameter of macular capillaries before and at 7days, 1 and 3months after starting topical anti-glaucoma medications
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Diagnosis
Device,equipment |
To take images of the human ocular fundus using scannning LASER ophthalmoscope (SLO), laser speckle flowgraphy (LSFG), and optical coherence tomography (OCT) before and at 7days, 1 and 3months after starting topical anti-glaucoma medications.
20 | years-old | <= |
Not applicable |
Male and Female
Patient
1) Male or female older than 20 years-old
2) patients with glaucoma or ocular hypertension
3) Subjects who sign an informed consent form to participate in the clinical study
1) Having any side-effects (hypersensitivity, rised intraocular pressure etc.) against mydriatics
2) Revealed narrow angle by slit-lamp examination
3) When a doctor accepted the middle-class above-mentioned cataract
4) Subjects who a doctor in attendance declares ineligible for any reason
160
1st name | |
Middle name | |
Last name | Nagahisa Yoshimura |
Kyoto University Graduate School of Medicine
Ophthalmology & Visual Sciences
54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, JAPAN
+81-75-751-3248
eye@med.kyoto-u.ac.jp
1st name | |
Middle name | |
Last name | Hideo Nakanishi |
Kyoto University Graduate School of Medicine
Ophthalmology & Visual Sciences
54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, JAPAN
+81-75-751-3248
eye@med.kyoto-u.ac.jp
Department of Ophthalmology & Visual Sciences, Kyoto University Graduate School of Medicine
Ministry of Education, Culture, Sports, Science and Technology (MEXT)
Japanese Governmental office
CANON INC.
NO
2014 | Year | 09 | Month | 25 | Day |
Published
Completed
2014 | Year | 09 | Month | 25 | Day |
2014 | Year | 10 | Month | 13 | Day |
2016 | Year | 03 | Month | 31 | Day |
2014 | Year | 09 | Month | 25 | Day |
2018 | Year | 03 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017450
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |